SAN FRANCISCO, July 17, 2023 (GLOBE NEWSWIRE) Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit.
See the latest ImmunityBio Inc Ordinary Shares stock price (NASDAQ:IBRX), related news, valuation, dividends and more to help you make your investing decisions.
ImmunityBio Inc. (NASDAQ:IBRX) went up by 3.19% from its latest closing price compared to the recent 1-year high of $9.99. The company’s stock price has collected -7.00% of loss in the last five trading sessions. Is It Worth Investing in ImmunityBio Inc. (NASDAQ :IBRX) Right Now? Plus, the 36-mon